Chemical materials

AB1-11 (anti-CLDN6)

AB1-11 (anti-CLDN6)

AL-AB191929 / 10MG
Add to Inquiry
AB1-11 (anti-CLDN6)

AB1-11 (anti-CLDN6)

AL-AB191929 / 5MG
Add to Inquiry
AB1-11 (anti-CLDN6)

AB1-11 (anti-CLDN6)

AL-AB191929 / 1MG
Add to Inquiry
Lendalizumab (anti-Complement C5)

Lendalizumab (anti-Complement C5)

AL-AB191930 / 5MG
CAS No.:2210314-30-8
Add to Inquiry
Lendalizumab (anti-Complement C5)

Lendalizumab (anti-Complement C5)

AL-AB191930 / 100ΜG
CAS No.:2210314-30-8
Add to Inquiry
Lendalizumab (anti-Complement C5)

Lendalizumab (anti-Complement C5)

AL-AB191930 / 10MG
CAS No.:2210314-30-8
Add to Inquiry
Lendalizumab (anti-Complement C5)

Lendalizumab (anti-Complement C5)

AL-AB191930 / 1MG
CAS No.:2210314-30-8
Add to Inquiry
Netakimab (anti-IL-17A)

Netakimab (anti-IL-17A)

AL-AB191931 / 10MG
CAS No.:1796570-08-5
Add to Inquiry
Netakimab (anti-IL-17A)

Netakimab (anti-IL-17A)

AL-AB191931 / 1MG
CAS No.:1796570-08-5
Add to Inquiry
Netakimab (anti-IL-17A)

Netakimab (anti-IL-17A)

AL-AB191931 / 100ΜG
CAS No.:1796570-08-5
Add to Inquiry
Netakimab (anti-IL-17A)

Netakimab (anti-IL-17A)

AL-AB191931 / 5MG
CAS No.:1796570-08-5
Add to Inquiry
Xeligekimab (anti-IL-17A)

Xeligekimab (anti-IL-17A)

AL-AB191932 / 100ΜG
CAS No.:2382921-73-3
Add to Inquiry
Xeligekimab (anti-IL-17A)

Xeligekimab (anti-IL-17A)

AL-AB191932 / 1MG
CAS No.:2382921-73-3
Add to Inquiry
Xeligekimab (anti-IL-17A)

Xeligekimab (anti-IL-17A)

AL-AB191932 / 5MG
CAS No.:2382921-73-3
Add to Inquiry
Xeligekimab (anti-IL-17A)

Xeligekimab (anti-IL-17A)

AL-AB191932 / 10MG
CAS No.:2382921-73-3
Add to Inquiry
Fsn0503h (anti-Cathepsin S)

Fsn0503h (anti-Cathepsin S)

AL-AB191933 / 100ΜG
Add to Inquiry
Fsn0503h (anti-Cathepsin S)

Fsn0503h (anti-Cathepsin S)

AL-AB191933 / 10MG
Add to Inquiry
Fsn0503h (anti-Cathepsin S)

Fsn0503h (anti-Cathepsin S)

AL-AB191933 / 1MG
Add to Inquiry
Fsn0503h (anti-Cathepsin S)

Fsn0503h (anti-Cathepsin S)

AL-AB191933 / 5MG
Add to Inquiry
Navivumab (anti-HA)

Navivumab (anti-HA)

AL-AB191936 / 10MG
CAS No.:1443004-16-7
Add to Inquiry
Navivumab (anti-HA)

Navivumab (anti-HA)

AL-AB191936 / 5MG
CAS No.:1443004-16-7
Add to Inquiry
Navivumab (anti-HA)

Navivumab (anti-HA)

AL-AB191936 / 1MG
CAS No.:1443004-16-7
Add to Inquiry
Navivumab (anti-HA)

Navivumab (anti-HA)

AL-AB191936 / 100ΜG
CAS No.:1443004-16-7
Add to Inquiry
Duligotuzumab (anti-EGFR&HER3)

Duligotuzumab (anti-EGFR&HER3)

AL-AB191943 / 100ΜG
CAS No.:1314238-96-4
Add to Inquiry
Duligotuzumab (anti-EGFR&HER3)

Duligotuzumab (anti-EGFR&HER3)

AL-AB191943 / 10MG
CAS No.:1314238-96-4
Add to Inquiry
Duligotuzumab (anti-EGFR&HER3)

Duligotuzumab (anti-EGFR&HER3)

AL-AB191943 / 5MG
CAS No.:1314238-96-4
Add to Inquiry
Duligotuzumab (anti-EGFR&HER3)

Duligotuzumab (anti-EGFR&HER3)

AL-AB191943 / 1MG
CAS No.:1314238-96-4
Add to Inquiry
Stamulumab (anti-Myostatin)

Stamulumab (anti-Myostatin)

AL-AB191951 / 10MG
CAS No.:705287-60-1
Add to Inquiry
Stamulumab (anti-Myostatin)

Stamulumab (anti-Myostatin)

AL-AB191951 / 5MG
CAS No.:705287-60-1
Add to Inquiry
Stamulumab (anti-Myostatin)

Stamulumab (anti-Myostatin)

AL-AB191951 / 1MG
CAS No.:705287-60-1
Add to Inquiry
Stamulumab (anti-Myostatin)

Stamulumab (anti-Myostatin)

AL-AB191951 / 100ΜG
CAS No.:705287-60-1
Add to Inquiry
Keliximab (anti-CD4)

Keliximab (anti-CD4)

AL-AB191955 / 100ΜG
CAS No.:174722-30-6
Add to Inquiry
Keliximab (anti-CD4)

Keliximab (anti-CD4)

AL-AB191955 / 1MG
CAS No.:174722-30-6
Add to Inquiry
Keliximab (anti-CD4)

Keliximab (anti-CD4)

AL-AB191955 / 5MG
CAS No.:174722-30-6
Add to Inquiry
Keliximab (anti-CD4)

Keliximab (anti-CD4)

AL-AB191955 / 10MG
CAS No.:174722-30-6
Add to Inquiry
Minretumomab (anti-TAG-72)

Minretumomab (anti-TAG-72)

AL-AB191957 / 100ΜG
CAS No.:195189-17-4
Add to Inquiry
Minretumomab (anti-TAG-72)

Minretumomab (anti-TAG-72)

AL-AB191957 / 10MG
CAS No.:195189-17-4
Add to Inquiry
Minretumomab (anti-TAG-72)

Minretumomab (anti-TAG-72)

AL-AB191957 / 1MG
CAS No.:195189-17-4
Add to Inquiry
Minretumomab (anti-TAG-72)

Minretumomab (anti-TAG-72)

AL-AB191957 / 5MG
CAS No.:195189-17-4
Add to Inquiry
Dapirolizumab (anti-CD40L)

Dapirolizumab (anti-CD40L)

AL-AB191960 / 10MG
Add to Inquiry
Dapirolizumab (anti-CD40L)

Dapirolizumab (anti-CD40L)

AL-AB191960 / 5MG
Add to Inquiry
Dapirolizumab (anti-CD40L)

Dapirolizumab (anti-CD40L)

AL-AB191960 / 1MG
Add to Inquiry
Dapirolizumab (anti-CD40L)

Dapirolizumab (anti-CD40L)

AL-AB191960 / 100ΜG
Add to Inquiry
Suptavumab (anti-RSV-F )

Suptavumab (anti-RSV-F )

AL-AB191964 / 1MG
CAS No.:1629615-23-1
Add to Inquiry
Suptavumab (anti-RSV-F )

Suptavumab (anti-RSV-F )

AL-AB191964 / 5MG
CAS No.:1629615-23-1
Add to Inquiry
Suptavumab (anti-RSV-F )

Suptavumab (anti-RSV-F )

AL-AB191964 / 100ΜG
CAS No.:1629615-23-1
Add to Inquiry
Suptavumab (anti-RSV-F )

Suptavumab (anti-RSV-F )

AL-AB191964 / 10MG
CAS No.:1629615-23-1
Add to Inquiry
Brolucizumab (anti-VEGFA)

Brolucizumab (anti-VEGFA)

AL-AB191965 / 5MG
CAS No.:1531589-13-5
Add to Inquiry
Brolucizumab (anti-VEGFA)

Brolucizumab (anti-VEGFA)

AL-AB191965 / 1MG
CAS No.:1531589-13-5
Add to Inquiry
Brolucizumab (anti-VEGFA)

Brolucizumab (anti-VEGFA)

AL-AB191965 / 10MG
CAS No.:1531589-13-5
Add to Inquiry
LOCATIONS

Service location

Taipei, New Taipei, Keelung / Yilan / Hualien
Inquiry Cart

Your inquiry Cart total 0 items

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
Manage Cookies

Privacy Preference Center

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
View Privacy Policy

Manage Consent Settings

Necessary Cookies

Enable all
The operation of the website relies on these cookies, and you cannot disable them in the system. These cookies are usually set based on the actions you take (i.e., service requests), such as setting privacy preferences, logging in, or filling out forms. You can set your browser to block or prompt you about these cookies, but this may cause some website functions to stop working.